16:02 Dec 20
GlaxoSmithKline Pharmaceuticals Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
GlaxoSmithKline Pharmaceuticals Ltd.
Industry Pharmaceuticals
16:02 Dec 20
Quality
66/100
High Financial Strength
Valuation
14/100
Expensive Valuation
Technical
48/100
Technically Neutral
Strength
4
Weakness
6
Opportunity
1
Threats
0
38.56K
Market Cap (Cr)
57.12
PE Ratio
23.05
Price to Book Ratio
37.24
RSI
17.20 %
Net Profit Margin
Download Our App On:
